Staying Connected: a Mobile Health Study With the Noona® and Mobili-T® Systems

NCT05368025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2023-10-06

No results posted yet for this study

Summary

Mobile health applications are an attractive technological solution that facilitates access to care for patients conveniently and efficiently. Research has shown that remote mHealth delivery has improved patient reported outcomes of disease severity. While such outcomes have traditionally been collected at one point in time within a clinical setting, the potential exists to now gather patient perspectives remotely. Additionally, when combined with a mobile health device, mHealth apps can objectively monitor a treatment plan.

Before implementing a new technology, it is important to investigate how digital health technologies are best integrated into clinical workflows, and how more than one technology can work together to streamline the process. Additionally, it is important to understand the relative benefits of each system from a user perspective and identify how combined data can benefit clinical workflows. Therefore, the purposes of this project are to demonstrate how two technology companies can work together to assess the feasibility of implementing two related systems into one care pathway.

Conditions

  • Oropharynx Cancer

Interventions

DEVICE

Mobili-T/Noona

Use of two mobile health systems over a period of 6 months

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Jana Rieger, PhD · University of Alberta

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-17
Primary Completion
2022-12-01
Completion
2023-05-26
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05368025 on ClinicalTrials.gov